Table 2.
Time | Clone | %G1 | % S | %G2-M | %subG1 |
---|---|---|---|---|---|
24 hr | Vector-0% | 70.95±4.6 | 22.67±4.25 | 6.38±1.98 | 0.79±0.23 |
Vector-10% | 25.91±6.11a | 68.56±4.85a | 5.53±1.66 | 1.34±0.58 | |
hRSK4-0% | 51.55±8.81c | 30.67±6.56c | 17.78±2.36c | 1.44±0.4 | |
hRSK4-10% | 23.25±5.79a,c | 62.99±4.8a,c | 13.76±1.87a,c | 2.29±0.29 | |
ΔE21-0% | 43.47±2.13c | 37.36±3.53c | 19.17±2.0c | 2.22±0.48 | |
ΔE21-10% | 24.72±4.98a | 71.04±6.27a | 4.24±1.72a,b | 2.73±0.6 | |
48 hr | Vector-0% | 75.33±4.5 | 18.71±3.21 | 5.96±1.55 | 1.54±0.62 |
Vector-10% | 31.99±2.19a | 61.53±3.81a | 6.48±1.03 | 2±0.46 | |
hRSK4-0% | 53.61±4.04c | 22.91±2.94c | 23.48±2.45c | 2.46±0.74 | |
hRSK4-10% | 23.43±1.66a,c | 58.21±1.89a,c | 18.36±1.94a,c | 2.51±0.37 | |
ΔE21-0% | 45.68±3.11c | 29.71±2.48c | 24.62±1.63c | 2.98±0.94 | |
ΔE21-10% | 31.23±2.07a | 62.56±2.15a | 6.21±1.66a,b | 2.61±0.43 | |
72 hr | Vector-0% | 79.98±3.81 | 13.54±2.15 | 6.48±2.0 | 1.73±0.76 |
Vector-10% | 33.57±1.02a | 60.22±3.34a | 6.21±0.34 | 2.33±0.54 | |
hRSK4-0% | 54.48±1.56c | 28.6±5.11c | 16.92±1.56c | 3.28±0.48 | |
hRSK4-10% | 21.53±1.5a,c | 61.1±3.13a,c | 17.38±1.45a,c | 1.44±0.59 | |
ΔE21-0% | 45.11±0.9c | 35.78±4.78c | 19.11±1.0c | 4.7c±0.58 | |
ΔE21-10% | 30.86±1.45a,b | 61.47±1.66a | 7.66±1.67a,b | 2.14±0.48 | |
96 hr | Vector-0% | 76.56±2.34 | 16.25±2.38 | 7.18±1.448 | 4.53±0.58 |
Vector-10% | 29.4±5.36a | 63.77±2.33a | 6.83±1.34 | 2.5±0.66 | |
hRSK4-0% | 54.29±1.99c | 29.59±2.25c | 16.13±1.48c | 6.24±0.38c | |
hRSK4-10% | 14.47±3.19a,c | 70.92±2.28a,c | 14.61±2.43a,c | 2.17±0.8a,c | |
ΔE21-0% | 47.64±3.12c | 34.95±1.86c | 17.41±2.34c | 7.31±0.65c | |
ΔE21-10% | 29.44±1.01a,b | 63.34±3.3a | 7.22±1.41a,b | 2.53±0.46a |
Note: Data are presented as Mean ± SD. G1, S and G2 phase cells sum to 100% of viable cells. Sub-G1 are attached but dead cells.
significantly different from 0% serum counterpart (p<0.05);
significantly different from the intact hRSK4 counterpart (p<0.05);
significantly different from the vector counterpart (p<0.05).